Year: 2024
Type: article
Abstract: Over the past decade, immunotherapy has emerged as one of the most promising approaches to cancer treatment. Immunotherapy employing Immune-Checkpoint Inhibitors (ICIs), Adoptive Cell Transfer (ACT), Chimeric Antigen Receptor (CAR) engineered T cells and cancer vaccines, have generated encouraging responses in the treatment of various cancers, and effector anti tumor T cells are observed as major component in these measures.
Source: Journal on oncology
Author: Tanya Das
Institution: Bose Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Award: G1345456107
OpenAlex ID: W4409848749